Emergency Medicine Australasia announced that they will stop accepting pharmaceutical advertisement. They say that the move is a response to growing evidence about the effects of the drug industry in medicine and claims that industry distorts research findings.
The NHS in England could save £200m a year if it switched patients with hypertension from candesartan to losartan without any loss of clinical benefits. BMJ 2011 342, d890
Pfizer is planning to close its research and development plan in Kent as part of a plan to trim research spending from over $8bn to less than $7bn. They plan to focus on areas that offer the greatest promise such as cancer and vaccines.